Search Results for: Pharmaceuticals

Gilead's Remdesivir authorised for emergency use only

High-priced Covid-19 drug Remdesivir being misused by hospitals across India

The Department of Pharmaceuticals has received several complaints regarding the "indiscriminate use" of Remdesivir by hospitals and it has raised the issue with the Ministry of Health and Family Welfare.

Jul 24, 2020

bse sensex, nse nifty, 2017 closing, brexit, demonetisation, modi, donald trump

Sensex, Nifty gain as HDFC Bank adds to earnings momentum; financials shine

Indian shares climbed on Monday as HDFC Bank added to last week's strong earnings releases from IT companies, countering the impact of the surge in domestic coronavirus cases past one million.

Jul 20, 2020

CDSCO pulls up Glenmark for misleading claims on Covid-19 drug Fabiflu

CDSCO says Glenmark has not only put out misleading claims about FABIFLU but has also made the drug unaffordable for the common man of the country.

Jul 19, 2020

Zydus begins human trials for potential COVID-19 vaccine

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world's third worst-hit nation.

Jul 15, 2020

BioNTech and Pfizer's coronavirus vaccine shows potential in human trials

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.

Jul 2, 2020

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc's antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66), the company said.

Jun 23, 2020

Pharma powers Indian shares to three-month closing high

The NSE Nifty 50 index, which has recovered ground after taking a hit from worries about a violent border clash with China last week, ended up 0.65% at 10,311, its highest since March 11.

Jun 22, 2020

India lifts export ban on Trump-touted drug hydroxychloroquine

Manufacturers, except export-oriented units and those in special economic zones, would still have to supply 20% of their production to the domestic market, Gowda said.

Jun 11, 2020

Apple Watch ECG feature coming to Japan and Brazil

Japan's Pharmaceuticals and Medical Devices Agency (PMDA) recently updated its list of registered foreign manufacturers to include Apple as a certified entity, reports MacOtakara.

Jun 7, 2020

COVID-19 drug Remdesivir's price in India is a concern; Pharma cos free to set price

Gilead Sciences' signs non-exclusive license pact with four Indian drug majors to set their own price for Covid-19 drug Remdesivir. Following this move, many pharma distributors have been selling the experimental drug at Rs 7000 per vial. This will result in escalated treatment cost, to procure vials approximating to Rs 35,000 to Rs 42,000 for five doses.

Jun 5, 2020

India to send nearly 1,000 tonnes of paracetamol raw material to Europe

The Indian government in March put a hold on exports of several drugs including paracetamol to secure supplies for its people after the coronavirus outbreak disrupted the industry's supply chain globally.

May 6, 2020

What you need to know about coronavirus right now

Germany agrees on way to ease lockdown Germany's federal government and 16 states have agreed shops and some sports can restart under certain conditions, schools will gradually open for all pupils. Here' what you need to know.

May 6, 2020

India enters Lockdown 3.0 to battle coronavirus

India lockdown extended: Here's what's open, closed in red, orange, green zones

As the nationwide lockdown to break the chain of COVID-19 transmission is extended for two more weeks, here is a complete list of activities that are allowed and those which are prohibited across the country.

May 1, 2020

Rags to riches and back, BR Shetty, NRI billionaire, until he wasn't

From rags to riches and back, the story of NRI billionaire Bavaguthu Raghuram Shetty might seem like just another one on the face of it, but there's a lot more untold and unspoken about the man who rose to fame, glory and amassed a fortune of $4.2 billion in 2018, according to Forbes. Here's unravelling the mysteries and the mistakes that led to the phenomenal rise and unbelievable fall of a sprawling empire into a debt trap.

Apr 27, 2020

Price of rapid test kits capped at Rs 400 each; HC says private gains cannot be a priority

The Delhi High Court ordered that rapid test kits imported by Matrix Lab will now be sold for Rs 400 and not Rs 600.